SenesTech, Inc. (SNES)
| Previous close | 0.6999 |
| Open | 0.7000 |
| Bid | 0.6887 x 100 |
| Ask | 0.7741 x 100 |
| Day's range | 0.6900 - 0.7484 |
| 52-week range | 0.5200 - 17.4000 |
| Volume | |
| Avg. volume | 125,159 |
| Market cap | 3.826M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
SenesTech Announces First Quarter 2024 Financial Results
SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024.
- PR Newswire
SenesTech to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2024, ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company has scheduled a conference call that same day, Thursday, May 9, 2024, at 5:00 pm ET, to review the results.
- PR Newswire
SenesTech Launches Evolve™ Mouse
SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces that the Company has launched Evolve™ Mouse, utilizing a breakthrough fertility control solution, for the control of mouse infestations. Evolve Mouse is designated as a 'minimum risk' product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the environment. The Company will be accepting orders as of Monday, May 6
